MR cracks ‘age-doping” in international youth soccer
MRI has been adopted by the International Federation of Association Football as a definitive measure to ensure fair play.
MRI has been adopted by the International Federation of Association Football as a definitive measure to ensure fair play.
FIFA, the governing body for international soccer competition, launched a program of random MRI wrist screening this month to verify the age of players competing in the U-17 (under 17) World Cup, which is being hosted by Nigeria. The issue of fielding overage players has been around for some time because the global competition draws talent from many parts of the world where age cannot be clearly determined. With this method, FIFA will guarantee that all players are really biologically under 17, according to FIFA's chief medical officer, Prof. Jiri Dvorak.
“MRI can determine age below or over 17 with a certainty of 99%,” he said.
FIFA-sanctioned competitions had used x-rays for this purpose in the past. But several member associations raised concerns about the use of ionizing radiation. This led the organization to look to MRI instead, Dvorak said.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
